Skip to main content
. 2024 Feb 1;18:306–321. doi: 10.1016/j.xjon.2024.01.014

Figure 5.

Figure 5

A, Representative images of immunofluorescence staining for E-cadherin and vimentin in each cell line. Cells were treated with losartan and angiotensin II (200×). B, Quantification of staining with image analysis. Losartan treatment significantly increased E-cadherin or reduced vimentin in each cell line (P < .05). Treatment with combination losartan and angiotensin II returned vimentin and E-cadherin levels to baseline.